Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Voltage-gated calcium channel alpha Cav3.1 (CACNA1G) |
Target Info
|
Blocker |
[4] |
| References |
Top |
| REF 1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7316).
|
| REF 2 |
FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 005856.
|
| REF 3 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| REF 4 |
Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. Hear Res. 2007 Apr;226(1-2):52-60.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
